These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20288108)

  • 1. Studies on botulinum toxoid, types A and P; production of alum precipitated toxoids.
    NIGG C; HOTTLE GA
    J Immunol; 1947 Mar; 55(3):245-54. PubMed ID: 20288108
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on botulinum toxoid, types A and B; methods for determining antigenicity in animals.
    HOTTLE GA; NIGG C; LICHTY JA
    J Immunol; 1947 Mar; 55(3):255-62. PubMed ID: 20288109
    [No Abstract]   [Full Text] [Related]  

  • 3. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.
    STERNE M; WENTZEL LM
    J Immunol; 1950 Aug; 65(2):175-83. PubMed ID: 15436997
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF PRELIMINARY ADMINISTRATION OF TOXOID ON THE RESISTANCE OF MICE TO BOTULINUM TOXIN. (PRELIMINARY REPORT)].
    ZHUK LN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jul; 41():39-42. PubMed ID: 14247222
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunization of horses with botulinum toxoid.
    WHITE PG; APPLETON GS
    J Am Vet Med Assoc; 1960 Dec; 137():652-3. PubMed ID: 13784851
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of comparative experimental examinations of the therapeutic effect of antitoxin, formol toxoid and the combination of both on Cl. botulinum-(D)-toxin produced intoxication].
    KATIC RV
    Zentralbl Bakteriol Orig; 1956 Aug; 166(6):510-6. PubMed ID: 13361428
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on botulinum toxoids, types A and B; immunization of man.
    REAMES HR; KADULL PJ
    J Immunol; 1947 Apr; 55(4):309-24. PubMed ID: 20294484
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulism among penned pheasants and protection by vaccination with C1 toxoid.
    Kurazono H; Shimozawa K; Sakaguchi G; Takahashi M; Shimizu T; Kondo H
    Res Vet Sci; 1985 Jan; 38(1):104-8. PubMed ID: 3883454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows.
    Krüger M; Skau M; Shehata AA; Schrödl W
    Anaerobe; 2013 Oct; 23():97-101. PubMed ID: 23831724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on C. pyogenes antitoxin in relation to immunity; the production of C. pyogenes antitoxin in the serum of normal dairy cows following the inoculation of alum-precipitated toxoid and of a commercial toxoid.
    WEITZ B
    J Comp Pathol Ther; 1947 Oct; 57(4):279-85. PubMed ID: 20273227
    [No Abstract]   [Full Text] [Related]  

  • 11. The preparation of a potent toxin of Shigella dysenteriae (Shiga) on a semi-synthetic medium and its use for the preparation of an alum-precipitated toxoid.
    OLITZKI L; BICHOWSKY L
    J Immunol; 1946 Apr; 52():293-300. PubMed ID: 21026411
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization of the rural Bantu against diphtheria in the Northern Transvaal. I. Immunity produced after one, and after two, injections of alum-precipitated toxoid.
    EISELEN HH; ROBINSON M; MASON JH
    S Afr Med J; 1959 Oct; 33():881-4. PubMed ID: 13819738
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of enterotoxemia (pulpy kidney disease) in lambs by the use of alum precipitated toxoid.
    MUTH OH; MORRILL DR
    Am J Vet Res; 1946 Jul; 7():355-7. PubMed ID: 20998641
    [No Abstract]   [Full Text] [Related]  

  • 14. Field trials with Corynebacterium, pyogenes alum-precipitated toxoid.
    LOVELL R; FOGGIE A; PEARSON JK
    J Comp Pathol; 1950 Jul; 60(3):225-9. PubMed ID: 14814228
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunization of broiler chickens against type C botulism.
    Dohms JE; Allen PH; Cloud SS
    Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of purified sorbed botulinum toxoid type F. II. Activity of crude toxins and toxoids].
    Tsarapkin VP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Nov; 48(11):105-8. PubMed ID: 4944335
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on C. pyogenes antitoxin in relation to immunity; the effect of alum-precipitated toxoid and vaccine on the artificial infection of the udder of the ewe with C. pyogenes.
    WEITZ B; LANGRIDGE R
    J Comp Pathol Ther; 1947 Oct; 57(4):286-93. PubMed ID: 20273228
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids.
    WRIGHT GG; DUFF JT; FIOCK MA; DEVLIN HB; SODERSTROM RL
    J Immunol; 1960 Apr; 84():384-9. PubMed ID: 13846070
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular differences between type A botulinum neurotoxin and its toxoid.
    Singh BR; DasGupta BR
    Toxicon; 1989; 27(4):403-10. PubMed ID: 2728029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan.
    Torii Y; Sugimoto N; Kohda T; Kozaki S; Morokuma K; Horikawa Y; Ginnaga A; Yamamoto A; Takahashi M
    Jpn J Infect Dis; 2017 Jul; 70(4):423-429. PubMed ID: 28250257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.